Company Filing History:
Years Active: 2016
Title: Glenn Gregory Zipp: Innovator in Pyrazolo[1,5-a]pyrimidine-based Compounds
Introduction
Glenn Gregory Zipp is a notable inventor based in Robbinsville, NJ (US). He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pyrazolo[1,5-a]pyrimidine-based compounds. His research focuses on developing compounds that can be utilized in treating various diseases and disorders.
Latest Patents
Glenn Gregory Zipp holds a patent for "Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use." This patent describes compounds of the formula that are defined within the documentation. The compositions that include these compounds are aimed at treating, managing, and preventing diseases and disorders mediated by adaptor associated kinase 1 activity. He has 1 patent to his name, showcasing his innovative contributions to the field.
Career Highlights
Zipp is currently associated with Lexicon Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at Lexicon Pharmaceuticals has allowed him to collaborate with other talented professionals in the industry.
Collaborations
Some of his notable coworkers include Yingzhi Bi and Kenneth Gordon Carson. Their collective expertise contributes to the innovative environment at Lexicon Pharmaceuticals.
Conclusion
Glenn Gregory Zipp is a distinguished inventor whose work on pyrazolo[1,5-a]pyrimidine-based compounds has the potential to impact the treatment of various diseases. His contributions to medicinal chemistry are noteworthy and reflect his commitment to innovation in the field.